Reported 16,600,000 shares, unchanged from the prior quarter.
Reported value 32.5%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 15272000 |
| 2022-03-31 | 14608000 |
| 2022-06-30 | 14276000 |
| 2022-09-30 | 14774000 |
| 2022-12-31 | 14442000 |
| 2023-03-31 | 12280252 |
| 2023-06-30 | 16268000 |
| 2023-09-30 | 8415000 |
| 2023-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2023 | Reduced | 0 | -8,500,000 (-100.0%) | 0 | $0 | 2024-02-12 | |
| Q3 2023 | Reduced | 8,500,000 | -8,100,000 (-48.8%) | 2.87% | $8,415,000 | 2023-11-13 | |
| Q2 2023 | Unchanged | 16,600,000 | 0 (0.0%) | 4.56% | $16,268,000 | 2023-08-08 | |
| Q1 2023 | Unchanged | 16,600,000 | 0 (0.0%) | 3.35% | $12,280,252 | 2023-05-12 | |
| Q4 2022 | Unchanged | 16,600,000 | 0 (0.0%) | 3.72% | $14,442,000 | 2023-02-15 | |
| Q3 2022 | Unchanged | 16,600,000 | 0 (0.0%) | 4.06% | $14,774,000 | 2022-11-15 | |
| Q2 2022 | Unchanged | 16,600,000 | 0 (0.0%) | 3.36% | $14,276,000 | 2022-08-09 | |
| Q1 2022 | Unchanged | 16,600,000 | 0 (0.0%) | 2.99% | $14,608,000 | 2022-05-11 | |
| Q4 2021 | Unchanged | 16,600,000 | 0 (0.0%) | 3.05% | $15,272,000 | 2022-02-16 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
1 manager reported PARATEK PHARMACEUTICALS INC for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Bruce & Co Inc This report | Unchanged | 16,600,000 | 0 | 4.56% | $16,268,000 | 21 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 08, 2023
- Filing type
- 13F-HR
- Position type
- Cv 4.75%
Voting authority reported
- Sole
- 16,600,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.